A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, March 16, 2020. (Photo: Xinhua)

No report of serious adverse reactions from 60,000 COVID-19 vaccine trial participants, official said on Tuesday.